MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Robust Computation of Subcortical Functional Connectivity Guided by Quantitative Susceptibility Mapping: An Application in Parkinson’s Disease Diagnosis

    J. Qin, C. He, Y. Ma, X. Guan, M. Zhang (Hangzhou, China)

    Objective: In this study, we aimed to introduce and validate a method that incorporates quantitative susceptibility mapping (QSM) into the rs-fMRI analytical pipeline to achieve…
  • 2025 International Congress

    Genotypic and phenotypic characterization of the population living with Parkinson disease in the northwest region of Argentina

    C. Avila, G. Alvarado, L. Rojas-Vazquez, J. Diaz-Rearte, E. Franchello (San Miguel de Tucuman, Argentina)

    Objective: To conduct a demographic, phenotypic, and genotypic characterization of Parkinson's disease (PD) patients in northwest Argentina. Background: Despite PD's widespread nature, most genetic studies…
  • 2025 International Congress

    Prevalence and Characteristics of Glucocerebrosidase Genetic Variants in Nepalese Early-onset Parkinson’s Disease Patients

    R. Ojha, B. Gajurel, N. Gautam, R. Karn, R. Rajbhandari, S. Shahi, V. Sharma, S. Baidya, A. Bhattarai, A. Niraula, E. Tuladhar, A. Adhikari, Y. Tay, S. Lim, A. Tan (Kathmandu, Nepal)

    Objective: To evaluate the genotype and phenotype of early-onset Parkinson´s Disease (EOPD) in the Nepalese population. Background: A significant proportion of early-onset PD (EOPD) can…
  • 2025 International Congress

    Artificial Intelligence Unveils Genetic Etiologies in Parkinson’s Disease: Cases Clustered by Clinical Features

    G. Di Rauso, A. Ghibellini, F. Pirone, G. Franco, F. Arienti, E. Frattini, I. Trezzi, F. Cavallieri, L. Bononi, M. Gabbrielli, F. Valzania, E. Monfrini, A. Di Fonzo (Reggio Emilia, Italy)

    Objective: The aim of this study is to explore whether artificial intelligence (AI) can accurately cluster Parkinson’s Disease (PD) patients carrying different variants in PD-associated…
  • 2025 International Congress

    Association Between Hyperuricemia, Gout, and the Risk of Parkinson’s Disease: An Updated Systematic Review and Meta-Analysis

    F. Qtaishat, J. Yasin, R. Odat, M. Alsufi, A. Abunamoos (Irbid, Jordan)

    Objective: To explore and evaluate the association between gout, hyperuricemia, and Parkinson’s disease (PD) using a systematic review and meta-analysis, incorporating stratified analyses by age…
  • 2025 International Congress

    Impact of rare lysosomal gene variants on Parkinson’s disease

    K. Senkevich, S. Parlar, C. Chantereault, L. Liu, E. Yu, U. Rudakou, J. Ruskey, J. Ahmad, F. Asayesh, D. Spiegelman, C. Waters, O. Monchi, Y. Dauvilliers, N. Dupré, L. Greenbaum, S. Hassin-Baer, I. Miliukhina, A. Timofeeva, A. Emelyanov, S. Pchelina, R. Alcalay, Z. Gan-Or (Montreal, Canada)

    Objective: To investigate the contribution of rare variants in lysosomal genes to Parkinson’s disease (PD) susceptibility. Background: Variants in the lysosomal gene GBA1 are established…
  • 2025 International Congress

    Multiple Independent Current Control for Gait Disorders in Early Programming of Parkinson’s Disease

    N. Helvacı Yılmaz, B. Bolluk Kılıç, G. İbrahimova, ö. Köksal, S. Bostan, B. Arı, T. Zırh, G. Kenangil (Istanbul, Turkey)

    Objective: To investigate the effect of Multiple Independent Current Control (MICC) on gait of Parkinson’s Disease (PD) Background: Classical programming with the ring and segmented…
  • 2025 International Congress

    Preoperative Predictors of Post-DBS Cognitive Decline: Cardiac MIBG Imaging and Levodopa Burden as Risk Factors for Dementia in Parkinson’s Disease

    DG. Park, YS. Kim, MS. Kim, JH. Yoon (Suwon, Republic of Korea)

    Objective: To identify preoperative clinical and imaging predictors of post-deep brain stimulation (DBS) dementia in Parkinson's disease (PD) patients, focusing on multiple potential risk factors…
  • 2025 International Congress

    Long-term outcomes of subthalamic Deep Brain Stimulation in LRRK2 patients

    C. Lazaro Hernandez, A. Garrido Pla, A. Sanchez Gomez, A. Cadena Fernandez, J. Bejarano Hernandez, F. Valldeoriola Serra (Barcelona, Spain)

    Objective: To compare the basal characteristics and postoperative clinical outcomes of LRRK2 mutation carriers and idiopathic Parkinson’s disease patients treated with subthalamic deep brain stimulation…
  • 2025 International Congress

    Predicting Long Term Outcome of Gait Kinematics with Chronic Deep Brain Stimulation in Patients with Parkinson’s Disease

    J. Al Ali, S. Miocinovic, L. Mckay, J. Nocera, F. Isbaine, J. Tran, P. Testini, S. Triche, C. Esper, P. Aia, L. Scorr, L. Higginbotham, R. Tripathi, N. Au Yong, C. Buetefisch (Atlanta, USA)

    Objective: To determine variables that predict outcome of gait kinematics with chronic deep brain stimulation (DBS) of the subthalamic nucleus (STN) or globus pallidus internus…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley